Human umbilical cord mesenchymal stem cells (The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School)

人脐带间充质干细胞（南京大学医学院附属鼓楼医院)

Report date: 2025/03/27 15:21:27

Base Information

Drug NameHuman umbilical cord mesenchymal stem cells (The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
China Registration ClassN/A

Develop Information

Active CompaniesThe Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Inactive CompaniesN/A
Active IndicationsLupus Nephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A